Results 221 to 230 of about 3,166,261 (352)

β-catenin as a key regulator of the cisplatin response in tumor cells. [PDF]

Clin Exp Med
Saburi E, Moghbeli M.
europepmc   +1 more source

Effects of Chemotherapeutic Agents on Wounds Contaminated with Tumor Cells

, 1960
Imran Hatiboglu, George E. Moore, H. Wilkens, F. S. Hoffmeister   +3 more
openalex   +2 more sources

Prevention of SV40 Virus Oncogenesis in Hamsters. II. The Effect of Thymectomy on Induction of Tumor Resistance by SV40-Transformed Human Cells [PDF]

, 1967
Anthony J. Girardi, Robert A. Roosa
openalex   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

A Rare Case of Precocious Pseudopuberty Due to a SertoliLeydig Cell Tumor Originating from the Left Fallopian Tube [PDF]

, 1963
S Dokumov, D. Dekov
openalex   +1 more source

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

Molecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa, Julia Richert, Tomasz Stokowy, Alicja Staśczak, Mariusz Szajewski, Maciej Ciesielski, Petra M. Grešner, Bartłomiej Tomasik, Łukasz Arcimowicz, Agnieszka Stankiewicz, Grażyna Suchodolska, Elżbieta Senkus, Wiesław Kruszewski, Anna J. Żaczek, Aleksandra Markiewicz   +14 more
wiley   +1 more source

Redefining cancer care: harnessing circulating tumor cells' potential for improved diagnosis and prognosis. [PDF]

Cancer Cell Int
Janjua D, Chaudhary A, Joshi U, Tripathi T, Jaggi VK, Bharti AC.   +5 more
europepmc   +1 more source

Further Studies on the Oxidation of Extramitochondrial Reduced Nicotineamide-Adenine Dinucleotide in Landschuetz Ascites Tumor Cells [PDF]

, 1968
Y. Melnik, Leah Bloch-Frankenthal
openalex   +1 more source

The IFNγ‐CIITA‐MHC II axis modulates melanoma cell susceptibility to NK‐cell‐mediated cytotoxicity

Molecular Oncology, EarlyView.
Natural killer (NK) cells play a central role in anti‐melanoma immunity. However, melanoma cells adapt during co‐culture by upregulating CIITA and MHC II in response to interferon gamma (IFNγ), thereby evading NK‐cell lysis. Blocking IFNγ signaling or treatment with dimethyl fumarate/simvastatin counteracts this immune escape and maintains NK‐cell ...
Lena C. M. Krause, Rixa‐Mareike Köhn, Christian Ickes, Julia Lenger, Jonas Fischer, Sabrina Cappello, Ivan Bogeski   +6 more
wiley   +1 more source

VISTA expressed on tumor cells is regulated by m6A and influences immune microenvironment through STAT3/CCL22 in NSCLC. [PDF]

J Transl Med
Xu H, Shen K, Jiang B, Xu Q, Li B, Ke Z, Cheng Q, Zhu S, Wang D, Song Y, Lv T.   +10 more
europepmc   +1 more source